Skeletal Muscle Mitochondria in Ageing

NCT ID: NCT06539078

Last Updated: 2024-08-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-03-25

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Healthy ageing is associated with the loss of muscle mass and physical function. As a result, older people are limited in their independence. The aging of muscles typically begins around the age of 30. From this age onward, muscle strength, muscle mass, and the maximum oxygen uptake of muscles decrease. The reasons for this are not entirely clear, but it seems to be partly related to how oxygen moves from our blood vessels to the muscles and how muscles burn energy. The precise role of age and physical fitness, as well as whether exercise can counteract the effects of ageing, is still unknown. Therefore, in this study, we aim to investigate the muscle function of both physically active and inactive young and middle-aged individuals. We hypothesise that endurance training can mitigate some of the effects of ageing.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Healthy ageing is associated with a loss of muscle mass and physical function. This loss of physical function is underpinned by reductions in characteristics such as muscle strength, power, and maximal oxygen uptake (V̇O2max; reflecting exercise capacity). However, the causal contributors to these age-associated impairments, and the role of exercise training status in mitigating them, remain poorly defined. Skeletal muscle mitochondrial function has been proposed to be a key contributor to age-associated effects on physical function, however many conflicting results are present in the extant human literature. Moreover, diffusion of oxygen from capillaries to mitochondria is a key determinant of V̇O2max, however, whether the skeletal muscle diffusive capacity for oxygen (DmO2) declines with age is unknown. A new technique utilizing near-infrared spectroscopy (NIRS) will enable the non-invasive assessment of skeletal muscle diffusive capacity in young and elderly subjects for the first time to resolve this issue. The primary aims of this study are therefore to 1) compare DmO2 derived via NIRS between young sedentary, young endurance-trained, older sedentary, and older endurance-trained subjects; 2) to compare non-invasive (i.e. with NIRS and 31phosphorous magnetic resonance spectroscopy \[31P-MRS\]) and invasive (i.e. measures of mitochondrial morphology and respiration obtained by skeletal muscle biopsy) markers of mitochondrial function between the same groups, and 3) to assess the relationships between DmO2, mitochondrial measures and assessments of capillarization with functional measurements of muscle strength, power, and V̇O2max.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Young, sedentary participants

* Aged between 18-30 years
* Male or female
* Not currently engaging in any formal exercise training or competitive sports
* No chronic health conditions likely to affect exercise tolerance or the physiological responses to exercise

Maximal exercise test

Intervention Type OTHER

Participants will undertake an incremental ramp test on a cycle ergometer to determine maximal oxygen uptake (V̇O2max) and the gas exchange threshold (GET). Throughout the exercise test, muscle oxygenation and deoxygenation will be monitored by NIRS.

3D Ultrasound

Intervention Type OTHER

Muscle volume and morphological characteristics will be assessed via 3D ultrasound imaging.

Dynamometry

Intervention Type OTHER

To determine the contractile properties of the knee extensors, participants will perform maximal isometric and isoinertial contractions of the knee extensors on a dynamometer.

Exercise test and occlusions

Intervention Type OTHER

Participants will perform a series of moderate-intensity constant power output exercise bouts on a cycle ergometer following which the recovery rates of muscle V̇O2 will be determined via a series of intermittent arterial occlusions. Throughout all tests, pulmonary gas exchange and ventilation will be determined and muscle oxygenation and deoxygenation will be monitored by NIRS.

Exercise test in MRI

Intervention Type OTHER

Exercise will be performed on a custom-built magnetic resonance-compatible cycle ergometer in supine position for determination of muscle phosphocreatine recovery kinetics using 31phosphorous magnetic resonance spectroscopy \[31P-MRS\].

Muscle biopsy

Intervention Type PROCEDURE

A muscle biopsy will be obtained from the vastus lateralis using a modified Bergström needle technique with suction.

Young endurance-trained participants

* Aged between 18-30 years
* Male or female
* Currently engaging in formal training (at least 3 times per week) in competitive endurance sports (i.e. running, cycling, swimming, triathlon, etc.)
* No chronic health conditions likely to affect exercise tolerance or the physiological responses to exercise

Maximal exercise test

Intervention Type OTHER

Participants will undertake an incremental ramp test on a cycle ergometer to determine maximal oxygen uptake (V̇O2max) and the gas exchange threshold (GET). Throughout the exercise test, muscle oxygenation and deoxygenation will be monitored by NIRS.

3D Ultrasound

Intervention Type OTHER

Muscle volume and morphological characteristics will be assessed via 3D ultrasound imaging.

Dynamometry

Intervention Type OTHER

To determine the contractile properties of the knee extensors, participants will perform maximal isometric and isoinertial contractions of the knee extensors on a dynamometer.

Exercise test and occlusions

Intervention Type OTHER

Participants will perform a series of moderate-intensity constant power output exercise bouts on a cycle ergometer following which the recovery rates of muscle V̇O2 will be determined via a series of intermittent arterial occlusions. Throughout all tests, pulmonary gas exchange and ventilation will be determined and muscle oxygenation and deoxygenation will be monitored by NIRS.

Exercise test in MRI

Intervention Type OTHER

Exercise will be performed on a custom-built magnetic resonance-compatible cycle ergometer in supine position for determination of muscle phosphocreatine recovery kinetics using 31phosphorous magnetic resonance spectroscopy \[31P-MRS\].

Muscle biopsy

Intervention Type PROCEDURE

A muscle biopsy will be obtained from the vastus lateralis using a modified Bergström needle technique with suction.

Middle-aged, sedentary participants

* Aged between 50-65 years
* Male or female
* Not currently engaging in any formal exercise training or competitive sports
* No chronic health conditions likely to affect exercise tolerance or the physiological responses to exercise

Maximal exercise test

Intervention Type OTHER

Participants will undertake an incremental ramp test on a cycle ergometer to determine maximal oxygen uptake (V̇O2max) and the gas exchange threshold (GET). Throughout the exercise test, muscle oxygenation and deoxygenation will be monitored by NIRS.

3D Ultrasound

Intervention Type OTHER

Muscle volume and morphological characteristics will be assessed via 3D ultrasound imaging.

Dynamometry

Intervention Type OTHER

To determine the contractile properties of the knee extensors, participants will perform maximal isometric and isoinertial contractions of the knee extensors on a dynamometer.

Exercise test and occlusions

Intervention Type OTHER

Participants will perform a series of moderate-intensity constant power output exercise bouts on a cycle ergometer following which the recovery rates of muscle V̇O2 will be determined via a series of intermittent arterial occlusions. Throughout all tests, pulmonary gas exchange and ventilation will be determined and muscle oxygenation and deoxygenation will be monitored by NIRS.

Exercise test in MRI

Intervention Type OTHER

Exercise will be performed on a custom-built magnetic resonance-compatible cycle ergometer in supine position for determination of muscle phosphocreatine recovery kinetics using 31phosphorous magnetic resonance spectroscopy \[31P-MRS\].

Muscle biopsy

Intervention Type PROCEDURE

A muscle biopsy will be obtained from the vastus lateralis using a modified Bergström needle technique with suction.

Middle-aged endurance-trained participants

* Aged between 50-65 years
* Male or female
* Currently engaging in formal training (at least 3 times per week) in competitive endurance sports (i.e. running, cycling, swimming, triathlon, etc.)
* No chronic health conditions likely to affect exercise tolerance or the physiological responses to exercise

Maximal exercise test

Intervention Type OTHER

Participants will undertake an incremental ramp test on a cycle ergometer to determine maximal oxygen uptake (V̇O2max) and the gas exchange threshold (GET). Throughout the exercise test, muscle oxygenation and deoxygenation will be monitored by NIRS.

3D Ultrasound

Intervention Type OTHER

Muscle volume and morphological characteristics will be assessed via 3D ultrasound imaging.

Dynamometry

Intervention Type OTHER

To determine the contractile properties of the knee extensors, participants will perform maximal isometric and isoinertial contractions of the knee extensors on a dynamometer.

Exercise test and occlusions

Intervention Type OTHER

Participants will perform a series of moderate-intensity constant power output exercise bouts on a cycle ergometer following which the recovery rates of muscle V̇O2 will be determined via a series of intermittent arterial occlusions. Throughout all tests, pulmonary gas exchange and ventilation will be determined and muscle oxygenation and deoxygenation will be monitored by NIRS.

Exercise test in MRI

Intervention Type OTHER

Exercise will be performed on a custom-built magnetic resonance-compatible cycle ergometer in supine position for determination of muscle phosphocreatine recovery kinetics using 31phosphorous magnetic resonance spectroscopy \[31P-MRS\].

Muscle biopsy

Intervention Type PROCEDURE

A muscle biopsy will be obtained from the vastus lateralis using a modified Bergström needle technique with suction.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Maximal exercise test

Participants will undertake an incremental ramp test on a cycle ergometer to determine maximal oxygen uptake (V̇O2max) and the gas exchange threshold (GET). Throughout the exercise test, muscle oxygenation and deoxygenation will be monitored by NIRS.

Intervention Type OTHER

3D Ultrasound

Muscle volume and morphological characteristics will be assessed via 3D ultrasound imaging.

Intervention Type OTHER

Dynamometry

To determine the contractile properties of the knee extensors, participants will perform maximal isometric and isoinertial contractions of the knee extensors on a dynamometer.

Intervention Type OTHER

Exercise test and occlusions

Participants will perform a series of moderate-intensity constant power output exercise bouts on a cycle ergometer following which the recovery rates of muscle V̇O2 will be determined via a series of intermittent arterial occlusions. Throughout all tests, pulmonary gas exchange and ventilation will be determined and muscle oxygenation and deoxygenation will be monitored by NIRS.

Intervention Type OTHER

Exercise test in MRI

Exercise will be performed on a custom-built magnetic resonance-compatible cycle ergometer in supine position for determination of muscle phosphocreatine recovery kinetics using 31phosphorous magnetic resonance spectroscopy \[31P-MRS\].

Intervention Type OTHER

Muscle biopsy

A muscle biopsy will be obtained from the vastus lateralis using a modified Bergström needle technique with suction.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

In order to be eligible to participate in this study, young sedentary participants must meet all of the following criteria:

* Aged between 18-30 years
* Male or female
* Not currently engaging in any formal exercise training or competitive sports
* No chronic health conditions likely to affect exercise tolerance or the physiological responses to exercise

In order to be eligible to participate in this study, young trained participants must meet all of the following criteria:

* Aged between 18-30 years
* Male or female
* Currently engaging in formal training (at least 3 times per week) in competitive endurance sports
* No chronic health conditions likely to affect exercise tolerance or the physiological responses to exercise

In order to be eligible to participate in this study, older sedentary participants must meet all of the following criteria:

* Aged between 50-65 years
* Male or female
* Not currently engaging in any formal exercise training or competitive sports
* No chronic health conditions likely to affect exercise tolerance or the physiological responses to exercise

In order to be eligible to participate in this study, older trained participants must meet all of the following criteria:

* Aged between 50-65 years
* Male or female
* Currently engaging in formal training (at least 3 times per week) in competitive endurance sports
* No chronic health conditions likely to affect exercise tolerance or the physiological responses to exercise

Exclusion Criteria

* Age that falls outside of 18-30 years (young groups) or 50-65 years (middle-aged groups)
* Inability to provide informed consent
* History of claustrophobia
* Ineligibility to perform the exercise test described in this study protocol or follow instructions
* Taking any medications known to interfere with the physiological responses to exercise, e.g. e.g. systemic corticosteroids, statins, SGLT2 inhibitors, GLP1 receptor agonists
* Contraindication for MRI (e.g. pacemaker, claustrophobia)
* Being under investigation for non-diagnosed disease at the time of investigation
* Body Mass Index (BMI) \>30 due to adiposity, since this is known to cause difficulties in obtaining muscle biopsies and NIRS measurements
* Pregnancy
* Are current smokers or have been a regular smoker within the last 12 months
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VU University of Amsterdam

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr Richie Goulding

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Richie Goulding, PhD

Role: PRINCIPAL_INVESTIGATOR

VU University of Amsterdam

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Vrije Universiteit Amsterdam

Amsterdam, North Holland, Netherlands

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ellen Breedveld, MSc

Role: CONTACT

+31636318844

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ellen Breedveld, MSc

Role: primary

+31636318844

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023.0746

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Muscle Biopsies in Healthy Volunteers
NCT01431677 TERMINATED NA